Remco Nagel

5.8k total citations · 4 hit papers
26 papers, 4.4k citations indexed

About

Remco Nagel is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Remco Nagel has authored 26 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Remco Nagel's work include RNA modifications and cancer (9 papers), MicroRNA in disease regulation (8 papers) and Epigenetics and DNA Methylation (4 papers). Remco Nagel is often cited by papers focused on RNA modifications and cancer (9 papers), MicroRNA in disease regulation (8 papers) and Epigenetics and DNA Methylation (4 papers). Remco Nagel collaborates with scholars based in Netherlands, Italy and Israel. Remco Nagel's co-authors include Reuven Agami, Carlos le Sage, Mariëtte Schrier, P. Mathijs Voorhoeve, David A. Egan, Anton Berns, Ekaterina A. Semenova, Joachim A.F. Oude Vrielink, Alexander Griekspoor and Hiroshi Nojima and has published in prestigious journals such as Cell, Nucleic Acids Research and Genes & Development.

In The Last Decade

Remco Nagel

26 papers receiving 4.3k citations

Hit Papers

A Genetic Screen Implicates miRNA-372 and miRNA-373 As On... 2006 2026 2012 2019 2006 2008 2007 2007 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors
    2006 1.0k citations P. Mathijs Voorhoeve, Carlos le Sage et al. Cell profile →
  2. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis
    2008 800 citations Qihong Huang, Kiranmai Gumireddy et al. Nature Cell Biology profile →
  3. Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferation
    2007 651 citations Carlos le Sage, Remco Nagel et al. The EMBO Journal profile →
  4. RNA-Binding Protein Dnd1 Inhibits MicroRNA Access to Target mRNA
    2007 591 citations Martijn Kedde, Bijan Boldajipour et al. Cell profile →

Peers

Remco Nagel
Arti Gaur United States
David Cogdell United States
Michael G. Kharas United States
Olga Aprelikova United States
David Sarrió Spain
Ralf Lesche Germany
Claudio R. Alarcón United States
Keiichi Ohshima Japan
Håkan Axelson Sweden
Purificacı́on Muñoz Spain
Arti Gaur United States
Remco Nagel
Citations per year, relative to Remco Nagel Remco Nagel (= 1×) peers Arti Gaur

Countries citing papers authored by Remco Nagel

Since Specialization
Citations

This map shows the geographic impact of Remco Nagel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Remco Nagel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Remco Nagel more than expected).

Fields of papers citing papers by Remco Nagel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Remco Nagel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Remco Nagel. The network helps show where Remco Nagel may publish in the future.

Co-authorship network of co-authors of Remco Nagel

This figure shows the co-authorship network connecting the top 25 collaborators of Remco Nagel. A scholar is included among the top collaborators of Remco Nagel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Remco Nagel. Remco Nagel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagel, Remco, Onno B. Bleijerveld, Natalie Proost, et al.. (2024). Chemotherapeutic agents and leucine deprivation induce codon-biased aberrant protein production in cancer. Nucleic Acids Research. 52(22). 13964–13979. 2 indexed citations
2.
Nagel, Remco, Abhijeet Pataskar, Julien Champagne, & Reuven Agami. (2022). Boosting Antitumor Immunity with an Expanded Neoepitope Landscape. Cancer Research. 82(20). 3637–3649. 9 indexed citations
3.
Champagne, Julien, Abhijeet Pataskar, Remco Nagel, et al.. (2021). Oncogene-dependent sloppiness in mRNA translation. Molecular Cell. 81(22). 4709–4721.e9. 30 indexed citations
4.
Shenoy, Anjana, Nishanth Belugali Nataraj, Gili Perry, et al.. (2020). Proteomic patterns associated with response to breast cancer neoadjuvant treatment. Molecular Systems Biology. 16(9). e9443–e9443. 38 indexed citations
5.
Nagel, Remco, Nanne Aben, Natalie Proost, et al.. (2019). Inhibition of the Replication Stress Response Is a Synthetic Vulnerability in SCLC That Acts Synergistically in Combination with Cisplatin. Molecular Cancer Therapeutics. 18(4). 762–770. 25 indexed citations
6.
Sun, Jianhui, Remco Nagel, Esther A. Zaal, et al.. (2019). SLC 1A3 contributes to L‐asparaginase resistance in solid tumors. The EMBO Journal. 38(21). e102147–e102147. 48 indexed citations
7.
Lopes, Rui, Gözde Korkmaz, Sonia Aristín Revilla, et al.. (2018). CUEDC1 is a primary target of ERα essential for the growth of breast cancer cells. Cancer Letters. 436. 87–95. 6 indexed citations
8.
Nagel, Remco, Ekaterina A. Semenova, & Anton Berns. (2016). Drugging the addict: non‐oncogene addiction as a target for cancer therapy. EMBO Reports. 17(11). 1516–1531. 108 indexed citations
9.
Nagel, Remco, Marijke Stigter‐van Walsum, Marijke Buijze, et al.. (2015). Genome-wide siRNA Screen Identifies the Radiosensitizing Effect of Downregulation of MASTL and FOXM1 in NSCLC. Molecular Cancer Therapeutics. 14(6). 1434–1444. 32 indexed citations
10.
Semenova, Ekaterina A., Remco Nagel, & Anton Berns. (2015). Origins, genetic landscape, and emerging therapies of small cell lung cancer. Genes & Development. 29(14). 1447–1462. 176 indexed citations
11.
Kemp, Sanne R. Martens‐de, Remco Nagel, Marijke Stigter‐van Walsum, et al.. (2013). Functional Genetic Screens Identify Genes Essential for Tumor Cell Survival in Head and Neck and Lung Cancer. Clinical Cancer Research. 19(8). 1994–2003. 68 indexed citations
12.
Nagel, Remco, et al.. (2013). Treatment response of HPV-positive and HPV-negative head and neck squamous cell carcinoma cell lines. Oral Oncology. 49(6). 560–566. 62 indexed citations
13.
Nagel, Remco, Linda Clijsters, & Reuven Agami. (2009). The miRNA‐192/194 cluster regulates the Period gene family and the circadian clock. FEBS Journal. 276(19). 5447–5455. 104 indexed citations
14.
Nagel, Remco, Carlos le Sage, Begoña Diosdado, et al.. (2008). Regulation of the Adenomatous Polyposis Coli Gene by the miR-135 Family in Colorectal Cancer. Cancer Research. 68(14). 5795–5802. 392 indexed citations
15.
Huang, Qihong, Kiranmai Gumireddy, Mariëtte Schrier, et al.. (2008). The micrornas mir-373 and mir-520c promote tumor migration, invasion and metastasis. Cancer Research. 68. 5015–5015. 1 indexed citations
16.
Huang, Qihong, Kiranmai Gumireddy, Mariëtte Schrier, et al.. (2008). The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nature Cell Biology. 10(2). 202–210. 800 indexed citations breakdown →
17.
Kedde, Martijn, Bijan Boldajipour, Joachim A.F. Oude Vrielink, et al.. (2007). RNA-Binding Protein Dnd1 Inhibits MicroRNA Access to Target mRNA. Cell. 131(7). 1273–1286. 591 indexed citations breakdown →
18.
Sage, Carlos le, Remco Nagel, & Reuven Agami. (2007). Diverse Ways to Control p27Kip1 Function: miRNAs Come into Play. Cell Cycle. 6(22). 2742–2749. 50 indexed citations
19.
Sage, Carlos le, Remco Nagel, David A. Egan, et al.. (2007). Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferation. The EMBO Journal. 26(15). 3699–3708. 651 indexed citations breakdown →
20.
Voorhoeve, P. Mathijs, Carlos le Sage, Mariëtte Schrier, et al.. (2006). A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors. Cell. 124(6). 1169–1181. 1023 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arti Gaur Breakdown of academic impact, for papers by David Cogdell Breakdown of academic impact, for papers by Michael G. Kharas Breakdown of academic impact, for papers by Olga Aprelikova Breakdown of academic impact, for papers by David Sarrió Breakdown of academic impact, for papers by Ralf Lesche Breakdown of academic impact, for papers by Claudio R. Alarcón Breakdown of academic impact, for papers by Keiichi Ohshima Breakdown of academic impact, for papers by Håkan Axelson Breakdown of academic impact, for papers by Purificacı́on Muñoz
Rankless by CCL
2026